Related Experiment Video
Updated: Jun 17, 2025
Mouse Kidney Transplantation: Models of Allograft Rejection
Published on: October 11, 2014
Understanding Pediatric Kidney Transplant Rejection: Its Pathophysiology, Biomarkers, and Management Strategies
Yuliya Semenova1, Mirgul Bayanova2, Saltanat Rakhimzhanova2
1Department of Surgery, Nazarbayev University School of Medicine, Astana, Kazakhstan.
Insights
Pediatric kidney transplant recipients face graft rejection challenges. This review explores new biomarkers and immunosuppressive therapies to improve survival and quality of life for these young patients.
Area of Science:
- Nephrology
- Pediatric Transplantation
- Immunology
Background:
- End-stage kidney disease necessitates advanced management, with kidney transplantation being the optimal treatment.
- Pediatric kidney transplant recipients require specialized care due to unique immune responses and the need for tailored immunosuppression.
- Despite advances, graft rejection remains a critical issue, impacting long-term outcomes in children.
Purpose of the Study:
- To review current knowledge on kidney transplant rejection in pediatric patients, covering epidemiology, pathophysiology, and risk factors.
- To explore advancements in non-invasive biomarkers for early rejection detection.
- To evaluate current and emerging immunosuppressive therapies for pediatric kidney transplantation.
Main Methods:
- Comprehensive literature review of recent studies on pediatric kidney transplant rejection.
- Analysis of epidemiological data, pathophysiological mechanisms, and identified risk factors.
- Evaluation of emerging diagnostic biomarkers and therapeutic strategies in immunosuppression.
Main Results:
- Significant improvements in graft and patient survival have been observed in the last decade.
- Graft rejection continues to be a major challenge, necessitating further research into early detection and management.
- There is a critical need for novel, non-invasive biomarkers and pediatric-specific immunosuppressive regimens.
Conclusions:
- Further research is needed to identify reliable non-invasive biomarkers for timely rejection detection in pediatric kidney transplant recipients.
- Development of tailored immunosuppressive strategies is crucial for improving long-term graft survival and patient quality of life.
- This review highlights research gaps and suggests future directions to enhance clinical practice and patient outcomes.
Abstract:
End-stage kidney disease requires comprehensive management strategies to ensure patient survival and improve quality of life. Kidney transplantation remains the preferred treatment option, offering superior long-term outcomes. However, graft rejection remains a significant concern, and pediatric patients often require tailored immunosuppressive regimens due to differences in immune response compared to adults. Although the past decade has seen significant improvements in graft and patient survival among pediatric kidney transplant recipients, many questions remain unanswered. There is an ongoing search for non-invasive biomarkers capable of timely detecting graft rejection and novel treatment regimens, specifically tailored to pediatric practice. This review aims to discuss the current knowledge on kidney transplant rejection in pediatric patients, including epidemiology, pathophysiology, and risk factors. In addition, it seeks to explore the latest advancements in biomarkers for early detection of rejection and evaluate current and emerging immunosuppressive therapies. The possible outcomes of this review include identifying gaps in current research, providing recommendations for future studies, and suggesting strategies to enhance clinical practice. By synthesizing the latest evidence, this review aims to contribute to improved long-term outcomes and quality of life for pediatric kidney transplant recipients.
